HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Coenzyme-A Technologies: Pro-Pointer, Inc. subsidiary introduces cosmeceutical Skin-Matrix Skin Treatment System, which "not only address[es] nutritional deficiencies, environmental stress from oxygen and sunlight, including the biologically persistent ubiquitous toxins of pollution but also the non-enzymatic-glycosylation processes that dramatically speed up the human skin's aging process," firm says May 6. Products contain company's C-Matrix, Glyco-Matrix, L-ascorbic acid, arabinogalactan (Siberian Larch tree) and camu-camu for vitamin C, as well as blueberry leaf, green tea and perilla seed extracts. "The uniqueness of the Skin-Matrix development is derived from the functional properties of its own individual ingredients, which upon blending undergo certain chemical reactions, thus creating a new synergistic super molecular structure similar to the extra cellular matrix of the human skin," according to Coenzyme-A President and CEO Nickolaos D. Skouras. Cost-effectiveness factors will contribute to "profit gains of up to 3,000%," firm says. "This translates to gross annual sales of well over $4.5 million," it adds. Company also sells coenzyme-A-based nutraceutical products online at 1www.Coenzyme-A.com
Advertisement

Related Content

Marketing In Brief
Marketing In Brief
Advertisement
UsernamePublicRestriction

Register

RS016931

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel